| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.892 | 43.482 | 53.509 | 55.164 | 101.025 | 24.559 | 11.912 | 7.857 |
| Total Income - EUR | - | - | 2.892 | 43.482 | 53.510 | 55.164 | 101.025 | 24.622 | 11.912 | 9.356 |
| Total Expenses - EUR | - | - | 691 | 27.953 | 41.382 | 31.889 | 69.901 | 32.982 | 23.927 | 22.575 |
| Gross Profit/Loss - EUR | - | - | 2.201 | 15.529 | 12.127 | 23.275 | 31.124 | -8.361 | -12.014 | -13.219 |
| Net Profit/Loss - EUR | - | - | 2.115 | 14.225 | 10.522 | 21.925 | 28.154 | -9.022 | -12.014 | -13.219 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dermasilk Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 49.867 | 44.079 | 69.446 | 77.647 | 63.666 | 54.617 | 45.233 | 35.708 |
| Current Assets | - | - | 3.067 | 24.169 | 10.084 | 25.437 | 69.663 | 22.034 | 19.110 | 16.626 |
| Inventories | - | - | 0 | 0 | 0 | 339 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 43 | 3.784 | 5.064 | 8.921 | 57.677 | 21.513 | 20.585 | 18.143 |
| Cash | - | - | 3.024 | 20.385 | 5.020 | 16.177 | 11.987 | 521 | -1.475 | -1.517 |
| Shareholders Funds | - | - | 2.158 | 16.344 | 26.549 | 47.970 | 42.640 | 23.916 | 11.830 | -1.456 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 50.776 | 51.905 | 52.981 | 55.114 | 90.689 | 52.734 | 52.513 | 53.790 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermasilk Srl